360 related articles for article (PubMed ID: 29653556)
1. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
2. Endometrial Polyps and Benign Endometrial Hyperplasia Have Increased Prevalence of DNA Fragmentation Factors 40 and 45 (DFF40 and DFF45) Together With the Antiapoptotic B-Cell Lymphoma (Bcl-2) Protein Compared With Normal Human Endometria.
Banas T; Pitynski K; Mikos M; Cielecka-Kuszyk J
Int J Gynecol Pathol; 2018 Sep; 37(5):431-440. PubMed ID: 28914671
[TBL] [Abstract][Full Text] [Related]
3. DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.
Banas T; Pitynski K; Okon K; Czerw A
Onco Targets Ther; 2017; 10():4579-4589. PubMed ID: 29075126
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status.
Banas T; Pitynski K; Okon K; Mikos M; Czerw AI; Deptała A; Ludwin A
Arch Med Sci; 2018 Oct; 14(6):1254-1262. PubMed ID: 30393479
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
Gu J; Dong RP; Zhang C; McLaughlin DF; Wu MX; Schlossman SF
J Biol Chem; 1999 Jul; 274(30):20759-62. PubMed ID: 10409614
[TBL] [Abstract][Full Text] [Related]
6. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45.
Zhou P; Lugovskoy AA; McCarty JS; Li P; Wagner G
Proc Natl Acad Sci U S A; 2001 May; 98(11):6051-5. PubMed ID: 11371636
[TBL] [Abstract][Full Text] [Related]
8. DFF45 expression in ovarian endometriomas.
Banas T; Skotniczny K; Basta A
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):87-91. PubMed ID: 19535198
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H
Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
[TBL] [Abstract][Full Text] [Related]
10. DFF45 expression in human endometrium is associated with menstrual cycle phases and decreases after menopause.
Banas T; Basta P; Knafel A; Skotniczny K; Jach R; Hajdyla-Banas I; Grabowska O
Gynecol Obstet Invest; 2012; 73(3):177-82. PubMed ID: 22378161
[TBL] [Abstract][Full Text] [Related]
11. Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity.
McCarty JS; Toh SY; Li P
Biochem Biophys Res Commun; 1999 Oct; 264(1):176-80. PubMed ID: 10527860
[TBL] [Abstract][Full Text] [Related]
12. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
14. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
15. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Bosse T; Nout RA; McAlpine JN; McConechy MK; Britton H; Hussein YR; Gonzalez C; Ganesan R; Steele JC; Harrison BT; Oliva E; Vidal A; Matias-Guiu X; Abu-Rustum NR; Levine DA; Gilks CB; Soslow RA
Am J Surg Pathol; 2018 May; 42(5):561-568. PubMed ID: 29505428
[TBL] [Abstract][Full Text] [Related]
16. Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.
Van Gool IC; Ubachs JEH; Stelloo E; de Kroon CD; Goeman JJ; Smit VTHBM; Creutzberg CL; Bosse T
Histopathology; 2018 Jan; 72(2):248-258. PubMed ID: 28795426
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of endometrial cancer patients with positive lymph nodes.
Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
19. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat.
Zhang C; Raghupathi R; Saatman KE; LaPlaca MC; McIntosh TK
J Neurochem; 1999 Oct; 73(4):1650-9. PubMed ID: 10501212
[TBL] [Abstract][Full Text] [Related]
20. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
